Omicron: booster shot of BioNTech Covid-19 vaccine provides enough protection against variant, Hong Kong researchers find

A booster shot of the German-made BioNTech coronavirus vaccine provides sufficient protection from the highly infectious Omicron variant, university researchers in Hong Kong have found.A study by a medical team from the University of Hong Kong and Chinese University found people’s neutralising antibodies – the first line of immune defence – diminished three to five weeks after they were inoculated with two doses of either the BioNTech vaccine, co-developed by Pfizer, or the Chinese-produced…

Read the original article at South China Morning Post